NORTHWEST BIOTHERAPEUTICS INC Annual Operating Margin in % from 2017 to 2023

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Northwest Biotherapeutics Inc quarterly/annual Operating Margin history and growth rate from 2017 to 2023.
  • Northwest Biotherapeutics Inc Operating Margin for the quarter ending March 31, 2024 was -4.36K %, a 38.9% decline year-over-year.
  • Northwest Biotherapeutics Inc annual Operating Margin for 2023 was -2.87K %, a 28% increase from 2022.
  • Northwest Biotherapeutics Inc annual Operating Margin for 2022 was -3.99K %, a 23.9% increase from 2021.
  • Northwest Biotherapeutics Inc annual Operating Margin for 2021 was -5.24K %, a 21.8% increase from 2020.
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -2.87K +1.12K +28% Jan 1, 2023 Dec 31, 2023
2022 -3.99K +1.25K +23.9% Jan 1, 2022 Dec 31, 2022
2021 -5.24K +1.46K +21.8% Jan 1, 2021 Dec 31, 2021
2020 -6.71K -5.55K -478% Jan 1, 2020 Dec 31, 2020
2019 -1.16K +8.91K +88.5% Jan 1, 2019 Dec 31, 2019
2018 -10.1K +6.21K +38.1% Jan 1, 2018 Dec 31, 2018
2017 -16.3K Jan 1, 2017 Dec 31, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.